Co-Authors
This is a "connection" page, showing publications co-authored by Niccolò Riccardi and Lucia Taramasso.
Connection Strength
1.542
-
Missed opportunities in tb clinical practice: How to bend the curve? A medical, social, economic and ethical point of view. Tuberculosis (Edinb). 2021 01; 126:102041.
Score: 0.230
-
Maintenance of Viral Suppression after Optimization Therapy from Etravirine Plus Raltegravir to Rilpivirine Plus Dolutegravir in HIV-1-Infected Patients. J Int Assoc Provid AIDS Care. 2019 Jan-Dec; 18:2325958218821657.
Score: 0.201
-
Time to change the single-centre approach to management of patients with tuberculosis: a novel network platform with automatic data import and data sharing. ERJ Open Res. 2018 Jan; 4(1).
Score: 0.188
-
Short Communication: Tenofovir Disoproxil Fumarate/Emtricitabine Fits for All as Appropriate HIV-1 Pre-Exposure Prophylaxis? AIDS Res Hum Retroviruses. 2018 02; 34(2):168-170.
Score: 0.188
-
Bedaquiline: A New Hope for Shorter and Better Anti-Tuberculosis Regimens. Recent Pat Antiinfect Drug Discov. 2018; 13(1):3-11.
Score: 0.187
-
Ibalizumab and Fostemsavir in the Management of Heavily Pre-Treated HIV-infected Patients. Recent Pat Antiinfect Drug Discov. 2018; 13(3):190-197.
Score: 0.187
-
Role of Raltegravir in patients co-infected with HIV and HCV in the era of direct antiviral agents. New Microbiol. 2017 Oct; 40(4):227-233.
Score: 0.184
-
Increasing prevalence of genitourinary schistosomiasis in Europe in the Migrant Era: Neglected no more? PLoS Negl Trop Dis. 2017 Mar; 11(3):e0005237.
Score: 0.177